We synthesize the world’s biomedical knowledge.
That’s great for humanity, right? Yes, but there’s a catch. Most of it is in text form, and there are millions of new documents per year. The problem is that each of us can only read a tiny portion of all that literature. What’s the point of having all that knowledge if we can't synthesize it and leverage it?
To tackle the challenge of synthesizing the world's biomedical knowledge, we knew that artificial intelligence (AI) could be a tremendous asset... but that AI alone would not be sufficient to achieve our goal. We recognized from Day 1 that we needed experts in the biomedical world to be an integral part of our team. That’s why nference is comprised of successful serial entrepreneurs from the tech space and PhDs in Biology/Genomics from MIT and Harvard Medical School.
Our knowledge synthesis platform - nferX - uses state-of-the-art Neural Networks (shallow and deep learning models) for real-time, automated extraction of knowledge from the commercial, scientific, and regulatory body of literature. The platform enables a diverse set of applications ranging from R&D to commercial strategy and operations in the life sciences ecosystem.
nferX as a service platform
Qrativ combines nference’s AI-driven knowledge synthesis capabilities with the clinical expertise and proprietary data of Mayo Clinic, the # 1 hospital in the US. This partnership revolutionizes the way new treatments are discovered and developed, particularly those for diseases with unmet medical need.
We are located at the heart of Kendall Square in Cambridge , MA—the world’s largest biotech hub.
101 Main Street, 14th floor
Cambridge, MA 02142